Dissecting brain tumor growth and metastasis in vitro and ex vivo

Abstract

Local infiltration and distal dissemination of tumor cells hamper efficacy of current treatments against central nervous system (CNS) tumors and greatly influence mortality and therapy-induced long-term morbidity in survivors. A number of in vitro and ex vivo assay systems have been established to better understand the infiltration and metastatic processes, to search for molecules that specifically block tumor cell infiltration and metastatic dissemination and to pre-clinically evaluate their efficaciousness. These systems allow analytical testing of tumor cell viability and motile and invasive capabilities in simplified and well-controlled environments. However, the urgent need for novel anti-metastatic therapies has provided an incentive for the further development of not only classical in vitro methods but also of novel, physiologically more relevant assay systems including organotypic brain slice culture. In this review, using publicly available peer-reviewed primary research and review articles, we provide an overview of a selection of in vitro and ex vivo techniques widely used to study growth and dissemination of primary metastatic brain tumors. Furthermore, we discuss how our steadily increasing knowledge of tumor biology and the tumor microenvironment could be integrated to improve current research methods for metastatic brain tumors. We believe that such rationally improved methods will ultimately increase our understanding of the biology of brain tumors and facilitate the development of more efficacious anti-metastatic treatments.

Keywords

Primary brain tumor / metastasis / in vitro model system / cell migration / organotypic brain slice culture

References

[1] Taylor MD,Korshunov A,Cho YJ,Parsons DW,Gajjar A,Lichter P,Pomeroy SL,Pfister SM.Molecular subgroups of medulloblastoma: the current consensus..Acta neuropathol2012;123:465-72 PMCID:PMC3306779

[2] Northcott PA,Peacock J,Morrissy AS,Stütz AM,Reimand J,Beroukhim R,Marshall CR,Mack S,Yao Y,Luu B,Cavalli FM,Remke M,Chiu RY,Chuah E,Hoad GR,Li Y,Mungall KL,Qian JQ,Thiessen NT,Birol I,Mungall AJ,Kawauchi D,Kool M,Witt H,Kenney AM,Dirks P,Grajkowska WA,Haberler CC,Reynaud SS,Pernet-Fattet SS,Kim SK,Scheurlen W,Fèvre-Montange M,Pollack IF,Muraszko KM,Di Rocco C,Michiels EM,French PJ,Olson JM,Zitterbart K,Thompson RC,Lach B,Bigner DD,Albrecht S,Lindsey JC,Gupta N,Bognár L,Van Meter TE,Tominaga T,Leonard JR,Liau LM,Fouladi M,Cinalli G,Hauser P,Iolascon A,Carlotti CG,Ra YS,Zollo M,Chan JA,Sorensen PH,Pomeroy SL,Bader GD,Hawkins CE,Scherer SW,Malkin D,Jones SJ,Pfister SM,Taylor MD.Subgroup-specific structural variation across 1,000 medulloblastoma genomes..Nat2012;488:49-56 PMCID:PMC3683624

[3] Northcott PA,H Witt H,Eberhart CG,Bouffet E,Hawkins CE,Rutka JT,Taylor MD.Medulloblastoma comprises four distinct molecular variants.J Clin Oncol2011;29:1408-14

[4] Kool M,Bunt J,Lakeman A,Troost D,Caron HN,Mrsić A,Grajkowska W,Pietsch T,Clifford SC.Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features..PLoS One2008;3:e3088

[5] Thompson MC,Hogg TL,Finkelstein D,Chintagumpala M,Ashley DM,Taylor MD,Gajjar A.Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations..J Clin Oncol2006;24:1924-31

[6] Wang X,Ramaswamy V,Gendoo DM,Wu X,Luu B,Peacock J,Skowron P,Lyden D,Cho YJ,MacDonald T,Van Meter T,Haibe-Kains B,Rutka JT,Pfister SM,Taylor MD.Medulloblastoma subgroups remain stable across primary and metastatic compartments..Acta neuropathol2015;129:449-57 PMCID:PMC4333718

[7] Angers-Loustau A,Werbowetski TE,Del Maestro RF.SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions..Mol Cancer Res2004;2:595-605

[8] Le PU,de Oliveira RM,Brassard CL,Brent H,Trinh G,Wang J,Bedell B,Petrecca K.DRR drives brain cancer invasion by regulating cytoskeletal-focal adhesion dynamics..Oncogene2010;29:4636-47

[9] Santhana Kumar K,Ma M,Egli KB,Shalaby T,Baumgartner M.The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma..SpringerPlus2015;4:19 PMCID:PMC4302160

[10] Rottner K.Actin dynamics and turnover in cell motility..Curr Opin Cell Biol2011;23:569-78

[11] Hall A.The cytoskeleton and cancer..Cancer Metastasis Rev2009;28:5-14

[12] Nurnberg A,Grosse R.Nucleating actin for invasion..Nat Rev Cancer2011;11:177-87

[13] Giese A,Berens ME.Cost of migration: invasion of malignant gliomas and implications for treatment..J Clin Oncol2003;21:1624-36

[14] Waclaw B,Pittman ME,Vogelstein B.A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity..Nat2015;525:261-4 PMCID:PMC4782800

[15] Palmer TD,Lewis JD.Targeting tumor cell motility to prevent metastasis..AdvDrug Deliv Rev2011;63:568-81 PMCID:PMC3132821

[16] Vehlow A.Invasion as target for therapy of glioblastoma multiforme..Biochim Biophys Acta2013;1836:236-44

[17] Wells A,Wheeler S,Lauffenburger D.Targeting tumor cell motility as a strategy against invasion and metastasis..Trends Pharmacol Sci2013;34:283-9 PMCID:PMC3640670

[18] Wolf K.Extracellular matrix determinants of proteolytic and non-proteolytic cell migration..Trends Cell Biol2011;21:736-44

[19] Ulrich TA,Tanner K,Kumar S.Probing cellular mechanobiology in three-dimensional culture with collagen-agarose matrices..Biomaterials2010;31:1875-84

[20] Friedl P.Plasticity of cell migration: a multiscale tuning model..J Cell Biol2010;188:11-19 PMCID:PMC2812848

[21] Cox TR.Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer..Dis Model Mech2011;4:165-78 PMCID:PMC3046088

[22] Rusert JM,Eberhart CG,Wechsler-Reya RJ.SnapShot: Medulloblastoma..Cancer Cell2014;26:940-40.e1

[23] Brochner CB,Mollgard K.Outer brain barriers in rat and human development..Front Neurosci2015;9:75 PMCID:PMC4360706

[24] Saboori P.Histology and Morphology of the Brain Subarachnoid Trabeculae..Anat Res Int2015;2015:279814

[25] Zimmermann DR.Extracellular matrix of the central nervous system: from neglect to challenge..Histochem Cell Biol2008;130:635-53

[26] Zurn AD.Regeneration failure in the CNs: cellular and molecular mechanisms..Adv Exp Med Biol2006;557:54-76

[27] Morgenstern DA,Fawcett JW.Chondroitin sulphate proteoglycans in the CNS injury response..Prog Brain Res2002;137:313-32

[28] Jones EV.Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease..Neural Plast2014;2014:321209

[29] Klekner A,Virga J,Toth J,Csősz é,Steiner L,Bognár L.Expression pattern of invasion-related molecules in the peritumoral brain..Clin Neurol Neurosurg2015;139:138-43

[30] Ulrich TA,Kumar S.The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells..Cancer Res2009;69:4167-74 PMCID:PMC2727355

[31] Kim SN,Halama K,Walte M,Schillers H,Senner V,Klämbt C.ECM stiffness regulates glial migration in Drosophila and mammalian glioma models..Dev2014;141:3233-42

[32] Rao SS,DeJesus J,Hissong A,Sarkar A.Inherent interfacial mechanical gradients in 3D hydrogels influence tumor cell behaviors..PLoS One2012;7:e35852

[33] Kim Y.CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility..Mol Cancer Res2014;12:1416-29 PMCID:PMC4201971

[34] Dvorak HF.Tumors: Wounds That Do Not Heal--Redux..Cancer Imunnol Res2015;3:1-11 PMCID:PMC4288010

[35] Halliday JJ.Connective tissue growth factor and the parallels between brain injury and brain tumors..J Natl Cancer Inst2011;103:1141-3

[36] Yang I,Kaur G,Parsa AT.The role of microglia in central nervous system immunity and glioma immunology..J Clin Neurosci2010;17:6-10 PMCID:PMC3786731

[37] Charles NA,Gilbertson R,Kettenmann H.The brain tumor microenvironment..Glia2011;59:1169-80

[38] Kerber M,Wickersheim A,Kiessling F,Tchaikovski V,Shibuya M,Machein MR.Flt-1 signaling in macrophages promotes glioma growth in vivo..Cancer Res2008;68:7342-51

[39] Strik HM,Meyermann R.Immune cell infiltration of intrinsic and metastatic intracranial tumours..Anticancer Res2004;24:37-42

[40] Margol AS,Gnanachandran J,Kennedy RJ,Finlay JL,Krieger MD,Fouladi M,Judkins AR,Asgharzadeh S.Tumor-associated macrophages in SHH subgroup of medulloblastomas..Clin Cancer Res2015;21:1457-65

[41] Placone AL,Searson PC.The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment..Tumour Biol2015;

[42] Kim JK,Sohn YW,Jeon HY,Ham SW,Chang SY,Yin J,Park JB,Kim H.Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling..Cancer Lett2014;353:194-200

[43] Rath BH,Jamal M,Tofilon PJ.Astrocytes enhance the invasion potential of glioblastoma stem-like cells..PLoS One2013;8:e54752

[44] Huang H,Kurrer M,Kleihues P.Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays..Cancer Res2000;60:6868-74

[45] Bhoopathi P,Gujrati M,Lakka SS.SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42..Cell Signal2011;23:1978-87 PMCID:PMC3184354

[46] Edwards LA,Son MJ,Lee J,Mantey SA,Song H,Jensen RT,Fine HA.Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion..J Natl Cancer Inst2011;103:1162-78 PMCID:PMC3149042

[47] Klein A,Sagi-Assif O,Izraely S,Bengaiev R,Nahmias C,Witz IP.Astrocytes facilitate melanoma brain metastasis via secretion of IL-23..J Pathol2015;236:116-27

[48] Zimmermann M,Eccles SA.Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays..Methods Mol Biol2013;986:227-52

[49] Matsusaki M,Akashi M.Three-dimensional cell culture technique and pathophysiology..Adv Drug Deliv Rev2014;74:95-103

[50] Astashkina A.Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments..Ad Drug Deliv Rev2014;69-70:1-18

[51] Weigelt B,Bissell MJ.The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer..Ad Drug Deliv Rev2014;69-70:42-51

[52] Thoma CR,Agarkova I,Krek W.3D cell culture systems modeling tumor growth determinants in cancer target discovery..Ad Drug Deliv Rev2014;69-70:29-41

[53] Hirata E,Kamioka Y,Miyamoto S,Sahai E.In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion..J Cell Sci2012;125:858-68

[54] Ivanov DP,Walker DA,Ashford MB,Garnett MC.In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment..J Biotechnol2015;205:3-13

[55] Morfouace M,Jacus M,3rd,Robinson S,Wang YD,Ayrault O,Puget S,Olson JM,Guy RK,Gajjar A.Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma..Cancer Cell2014;25:516-29 PMCID:PMC3994669

[56] Kumar KS,Kunze J,Weller M,Schneider G.Computer-assisted quantification of motile and invasive capabilities of cancer cells..Sci Rep2015;5:15338 PMCID:PMC4614254

[57] Ansari N,Stelzer EH.Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy..Methods Cell Biol2013;113:295-309

[58] Eichler M,Krinke D,Schmidt S,Robitzki AA.A novel 96-well multielectrode array based impedimetric monitoring platform for comparative drug efficacy analysis on 2D and 3D brain tumor cultures..Biosens Bioelectron2015;67:582-9

[59] Gritsenko PG,Friedl P.Interstitial guidance of cancer invasion..J Pathol2012;226:185-99

[60] Fernandez-Fuente G,Grande L,Fernandez-Luna JL.Culture dimensionality influences the resistance of glioblastoma stem-like cells to multikinase inhibitors..Mol Cancer Ther2014;13:1664-72

[61] Pagliarini R,Sellers WR.Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure..EMBO Rep2015;16:280-296 PMCID:PMC4364868

[62] Rao S,Short AR,Sarkar A.Glioblastoma Behaviors in Three-Dimensional Collagen-Hyaluronan Composite Hydrogels..ACS Appl Mate Interfaces2013;5:9276-84 PMCID:PMC4333346

[63] Florczyk SJ,Jana S,Sytsma SK,Kievit FM.Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM..Biomaterials2013;34:10143-50 PMCID:PMC3843957

[64] Pedron S,Harley BA.Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid..Biomaterials2013;34:7408-17

[65] Biggs T,Sundstrom L,Lehembre F.Antitumor compound testing in glioblastoma organotypic brain cultures..J Biomol Screening2011;16:805-17

[66] Rutka JT,Giblin JR,McCulloch JR.Growth of a medulloblastoma on normal leptomeningeal cells in culture: interaction of tumor cells and normal cells..Neurosurgery1987;21:872-8

[67] Humpel C.Organotypic brain slice cultures: A review..Neurosci2015;305:86-98 PMCID:PMC4699268

[68] Ma L,Zhou C,Zhang J,Foltz G,Honkakoski P.Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system..Biomaterials2012;33:4353-61 PMCID:PMC3569495

[69] Huh D,Ingber DE.From 3D cell culture to organs-on-chips..Trends Cell Biol2011;21:745-54 PMCID:PMC4386065

[70] Ghaemmaghami AM,Harrington H,Khademhosseini A.Biomimetic tissues on a chip for drug discovery..Drug Discov Today2012;17:173-81 PMCID:PMC3273552

[71] Jung S,Ivanchuk S,Becker LE.Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model..J Neurosurg2001;94:80-9

[72] Jung S,Lee JH,Rhu HH,Yang SY,Bae CS,Shin BA,Ahn KY.Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model..J Cancer Res Clin Oncol2002;128:469-76

[73] Shamir ER.Three-dimensional organotypic culture: experimental models of mammalian biology and disease..Nat Rev Mol Cell Biol2014;15:647-64 PMCID:PMC4352326

[74] Stoppini L,Muller D.A simple method for organotypic cultures of nervous tissue..J Neurosci Methods1991;37:173-82

[75] Ohnishi T,Izumoto S,Hayakawa T.A novel model of glioma cell invasion using organotypic brain slice culture..Cancer Res1998;58:2935-40

[76] Matsumura H,Kanemura Y,Yoshimine T.Quantitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model..Biochem Biophys Res Commun2000;269:513-20

[77] de Bouard S,Guillamo JS,Palfi S,Masset M,Peschanski M.Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis..J Neurosurg2002;97:169-76

[78] Palfi S,De Bouard S,Oliveira R,Kros JM,Christov C.Correlation of in vitro infiltration with glioma histological type in organotypic brain slices..Br J Cancer2004;91:745-52 PMCID:PMC2364801

[79] Chadwick EJ,Filbin MG,Sun Y,Pazyra-Murphy MF,Ligon KL,Segal RA.A brain tumor/organotypic slice co-culture system for studying tumor microenvironment and targeted drug therapies..J Vis Exp2015;e53304:

[80] Moser KV,Hinterhuber H.Brain capillaries and cholinergic neurons persist in organotypic brain slices in the absence of blood flow..Eur J Neurosci2003;18:85-94

[81] Hutter-Schmid B,Humpel C.Organotypic brain slice cultures as a model to study angiogenesis of brain vessels..Front Cell Dev Biol2015;3:52 PMCID:PMC4557061

[82] Caspani EM,Rottner K.Live imaging of glioblastoma cells in brain tissue shows requirement of actin bundles for migration..Neuron Glia Biol2006;2:105-14

[83] Baskin R,Mendoza-Fandino G,Egan KM.Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility..Sci Rep2015;5:17367 PMCID:PMC4661592

[84] Kessler J,Wichmann H,Kappler M,Vordermark D.IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status..Radiother Oncol2015;116:381-7

[85] Jung JH,Chang DY,Suh-Kim H.Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells..Am J Cancer Res2015;5:2686-96

[86] Smith SJ,Tan C,Rahman R.Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response..Oncotarget2015;6:22191-205 PMCID:PMC4673156

[87] Huang M,Sun X,Yang Z,Du M,Liu X.Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1alpha..Oncol Rep2014;32:1973-80

[88] Boutin ME.Application and assessment of optical clearing methods for imaging of tissue-engineered neural stem cell spheres..Tissue Eng Part C Methods2015;21:292-302 PMCID:PMC4346659

[89] He W,Xing X,Huang H,Chen J,Liu E,Gu J.Proteomic comparison of 3D and 2D glioma models reveals increased HLA-E expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity..J Proteome Res2014;13:2272-81

[90] Jiguet Jiglaire C,Denicolai E,Metellus P,Chinot O,Fernandez C.Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening..Exp Cell Res2014;321:99-108

[91] Lee KH,Lee J,Lee D,Lee SH.Integration of microfluidic chip with biomimetic hydrogel for 3D controlling and monitoring of cell alignment and migration..J Biomed Mater Res A2014;102:1164-72

[92] Levin VA,Shen L.Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures..Proteome Sci2012;10:5 PMCID:PMC3317865

[93] Kievit FM,Leung MC,Park JO.Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment..Biomaterials2010;31:5903-10 PMCID:PMC2883048

[94] An Z,Choy ML.Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture..Cancer Lett2010;292:215-27

[95] Sarkar S.Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix..Carcinogenesis2010;31:311-7

[96] Sarkar S.Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix..J Neurooncol2009;91:157-64

[97] Jamison S,Lin W.Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A..PLoS One2015;10:e0120252

[98] Bhatia S,Timofeeva O,Hirsch K,Dritschilo A,Henkemeyer M,Jung M,Kool M,Albanese C.Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization..Oncotarget2015;6:8929-46 PMCID:PMC4496193

[99] Dudu V,Rotari V,Vazquez M.Role of Epidermal Growth Factor-Triggered PI3K/Akt Signaling in the Migration of Medulloblastoma-Derived Cells..Cell Mol Bioeng2012;5:502-413 PMCID:PMC3832994

[100] Yuan L,Liu J,Cho YJ,Schniederjan M.Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration..Mol Cancer2013;12:18 PMCID:PMC3599655

[101] Werbowetski-Ogilvie TE,Jabado N,Agar NY,Bjerkvig R,Faury D,Del Maestro RF.Inhibition of medulloblastoma cell invasion by Slit..Oncogene2006;25:5103-12 PMCID:PMC2072874

[102] Morrison LC,Aiken C,Liang L,Di Curzio D,Taylor MD.Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes..Neoplasia2013;15:384-98 PMCID:PMC3612911